{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,3]],"date-time":"2026-05-03T04:16:56Z","timestamp":1777781816842,"version":"3.51.4"},"reference-count":49,"publisher":"SAGE Publications","issue":"12","license":[{"start":{"date-parts":[[2025,7,16]],"date-time":"2025-07-16T00:00:00Z","timestamp":1752624000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"funder":[{"name":"Health Education England","award":["Doctorate in Clinical Psychology"],"award-info":[{"award-number":["Doctorate in Clinical Psychology"]}]}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["J Atten Disord"],"published-print":{"date-parts":[[2025,10]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>This review aimed to systematically review and synthesize qualitative evidence of the experiences of adults with ADHD who engage in stimulant medication treatment. A secondary aim was to establish the factors that influence adherence behavior regarding stimulant medication treatment for ADHD and appraise the quality of existing research.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>Psych Info, Academic Search Complete, Embase, and Medline were searched between the 20th and 28th June 2024 for qualitative studies that explored the experiences of adults who had been prescribed stimulant medication for ADHD. A modified Critical Appraisal Skills Programme checklist was used to assess the risk of bias in included studies and a meta-ethnographic approach was used to synthesize the results.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>Forty-seven second-order constructs were identified from the 13 included papers (263 participants). Four third-order themes were identified: 1. Fitting in with society: Performance. 2. The impact of ADHD versus the side effects of stimulants. 3. Fitting in with society: Social functioning. 4. Difficulty accessing medication and specialist care. Further synthesis of these themes highlighted that access to a specialist doctor who was willing to \u201ctweak\u201d medication and dosage was both a key stimulus that triggered adherence behavior and a factor that influenced other stimuli for adherence behavior.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion:<\/jats:title>\n                    <jats:p>Adults consistently found ADHD medications to be effective at reducing symptoms of ADHD, but their experience of taking the medications varied greatly due to the range of social, psychological, and physical side effects that could occur. All participants spoke about their experiences of taking ADHD medications in the context of \u201cfitting in\u201d with society: Being able to perform academically and in the workplace, as well as being able to meet familial and friendship obligations. However, \u201cfitting in\u201d could be both a motivation for adherence and non-adherence to medication. Societal perceptions and stigma around ADHD and ADHD medications was also discussed as important context regarding \u201cfitting in\u201d and medication adherence. When the results were viewed through the lens of the Health Belief Model, it was highlighted that the four themes identified could be considered stimuli for adherence behavior. A potential methodical limitation of the review was the weighted synthesis approach, which prevented themes being generated from lower quality, less relevant studies. However this approach could also be considered a strength.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/10870547251349952","type":"journal-article","created":{"date-parts":[[2025,7,16]],"date-time":"2025-07-16T07:11:06Z","timestamp":1752649866000},"page":"1118-1133","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":1,"title":["What Are the Experiences of Adults With ADHD of Engaging in ADHD Medication Treatment? A Systematic Review and Meta-Ethnography"],"prefix":"10.1177","volume":"29","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-0183-5082","authenticated-orcid":false,"given":"Laura","family":"Reeves","sequence":"first","affiliation":[{"name":"University of Nottingham, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Tickle","sequence":"additional","affiliation":[{"name":"University of Nottingham, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","published-online":{"date-parts":[[2025,7,16]]},"reference":[{"key":"e_1_3_3_2_1","doi-asserted-by":"crossref","unstructured":"Able S. L. Johnston J. A. Adler L. A. Swindle R. W. (2007). Functional and psychosocial impairment in adults with undiagnosed ADHD. Psychological Medicine 37(1) 97\u2013107. https:\/\/doi.org\/10.1017\/S0033291706008713","DOI":"10.1017\/S0033291706008713"},{"key":"e_1_3_3_3_1","doi-asserted-by":"crossref","unstructured":"Adler L. A. Faraone S. V. Spencer T. J. Berglund P. Alperin S. Kessler R. C. (2017). The structure of adult ADHD. International Journal of Methods in Psychiatric Research 26(1) e1555. https:\/\/doi.org\/10.1002\/mpr.1555","DOI":"10.1002\/mpr.1555"},{"key":"e_1_3_3_4_1","doi-asserted-by":"crossref","unstructured":"American Psychiatric Association. (2013). Diagnostic and statistical manual of mental disorders. https:\/\/doi.org\/10.1176\/appi.books.9780890425596","DOI":"10.1176\/appi.books.9780890425596"},{"key":"e_1_3_3_5_1","doi-asserted-by":"crossref","unstructured":"Biederman J. Fried R. DiSalvo M. Woodworth K. Y. Biederman I. Driscoll H. Noyes E. Faraone S. V. Perlis R. H. (2020). Further evidence of low adherence to stimulant treatment in adult ADHD: An electronic medical record study examining timely renewal of a stimulant prescription. Psychopharmacology 237(9) 2835\u20132843. https:\/\/doi.org\/10.1007\/s00213-020-05576-y","DOI":"10.1007\/s00213-020-05576-y"},{"key":"e_1_3_3_6_1","doi-asserted-by":"crossref","unstructured":"Boland H. DiSalvo M. Fried R. Woodworth K. Y. Wilens T. Faraone S. V. Biederman J. (2020). A literature review and meta-analysis on the effects of ADHD medications on functional outcomes. Journal of Psychiatric Research 123 21\u201330. https:\/\/doi.org\/10.1016\/j.jpsychires.2020.01.006","DOI":"10.1016\/j.jpsychires.2020.01.006"},{"key":"e_1_3_3_7_1","doi-asserted-by":"crossref","unstructured":"Brattstr\u00f6m O. Eriksson M. Larsson E. Oldner A. (2015). Socio-economic status and co-morbidity as risk factors for trauma. European Journal of Epidemiology 30 151\u2013157. https:\/\/doi.org\/10.1007\/s10654-014-9969-1","DOI":"10.1007\/s10654-014-9969-1"},{"key":"e_1_3_3_8_1","doi-asserted-by":"crossref","unstructured":"Brod M. Pohlman B. Lasser R. Hodgkins P. (2012). Comparison of the burden of illness for adults with ADHD across seven countries: A qualitative study. Health and Quality of Life Outcomes 10 47. https:\/\/doi.org\/10.1186\/1477-7525-10-47","DOI":"10.1186\/1477-7525-10-47"},{"key":"e_1_3_3_9_1","doi-asserted-by":"crossref","unstructured":"Burnier M. (2024). The role of adherence in patients with chronic diseases. European Journal of Internal Medicine 119 1\u20135. https:\/\/doi.org\/10.1016\/j.ejim.2023.07.008","DOI":"10.1016\/j.ejim.2023.07.008"},{"key":"e_1_3_3_10_1","doi-asserted-by":"crossref","unstructured":"Carolan D. (2022). ADHD stimulant medication misuse and considerations for current prescribing practice: A literature review. Irish Journal of Medical Science (1971-) 191(1) 313\u2013320. https:\/\/doi.org\/10.1007\/s11845-020-02502-1","DOI":"10.1007\/s11845-020-02502-1"},{"key":"e_1_3_3_11_1","doi-asserted-by":"crossref","unstructured":"Charach A. Fernandez R. (2013). Enhancing ADHD medication adherence: Challenges and opportunities. Current Psychiatry Reports 15(7) 371. https:\/\/doi.org\/10.1007\/s11920-013-0371-6","DOI":"10.1007\/s11920-013-0371-6"},{"key":"e_1_3_3_12_1","doi-asserted-by":"crossref","unstructured":"Cripe E. T. LeBlanc S. S. Eilert M. Bernhardt K. (2024). Coming to terms with our racecar brains: Academic mothers experiencing adult diagnosis of ADHD. Health Communication 40(2) 1\u20134. https:\/\/doi.org\/10.1080\/10410236.2024.2331999","DOI":"10.1080\/10410236.2024.2331999"},{"key":"e_1_3_3_13_1","unstructured":"Critical Appraisal Skills Programme. (2018). CASP qualitative checklist. https:\/\/www.casp-uk.net\/casp-tools-checklists\/qua-litative-studies-checklist\/"},{"key":"e_1_3_3_14_1","doi-asserted-by":"crossref","unstructured":"Davis-Berman J. L. Pestello F. G. (2008). Medicating for ADD\/ADHD: Personal and social issues. International Journal of Mental Health and Addiction 8(3) 482\u2013492. https:\/\/doi.org\/10.1007\/s11469-008-9167-z","DOI":"10.1007\/s11469-008-9167-z"},{"key":"e_1_3_3_15_1","doi-asserted-by":"crossref","unstructured":"Druedahl L. C. K\u00e4lvemark Sporrong S. (2018). Managing complexity: Exploring decision making on medication by young adults with ADHD. Pharmacy 6(2) 33. https:\/\/doi.org\/10.3390\/pharmacy6020033","DOI":"10.3390\/pharmacy6020033"},{"key":"e_1_3_3_16_1","doi-asserted-by":"crossref","unstructured":"Druedahl L. C. K\u00e4lvemark Sporrong S. (2020). More than meets the eye: A Foucauldian perspective on treating ADHD with medicine. Research in Social and Administrative Pharmacy 16(9) 1201\u20131207. https:\/\/doi.org\/10.1016\/j.sapharm.2019.12.008","DOI":"10.1016\/j.sapharm.2019.12.008"},{"key":"e_1_3_3_17_1","doi-asserted-by":"crossref","unstructured":"Gast A. Mathes T. (2019). Medication adherence influencing factors: An (updated) overview of systematic reviews. Systematic Reviews 8(1) 112. https:\/\/doi.org\/10.1186\/s13643-019-1014-8","DOI":"10.1186\/s13643-019-1014-8"},{"key":"e_1_3_3_18_1","doi-asserted-by":"crossref","unstructured":"Ghosh M. Fisher C. Preen D. B. Holman C. D. A. J. (2016). It has to be fixed: A qualitative inquiry into perceived ADHD behaviour among affected individuals and parents in Western Australia. BMC Health Services Research 16(1) 141. https:\/\/doi.org\/10.1186\/s12913-016-1399-1","DOI":"10.1186\/s12913-016-1399-1"},{"key":"e_1_3_3_19_1","doi-asserted-by":"crossref","unstructured":"Godfrey E. Fuermaier A. B. M. Tucha L. Butzbach M. Weisbrod M. Aschenbrenner S. Tucha O. (2021). Public perceptions of adult ADHD: Indications of stigma? Journal of Neural Transmission 128(7) 993\u20131008. https:\/\/doi.org\/10.1007\/s00702-020-02279-8","DOI":"10.1007\/s00702-020-02279-8"},{"key":"e_1_3_3_20_1","doi-asserted-by":"crossref","unstructured":"Hire A. J. Ashcroft D. M. Springate D. A. Steinke D. T. (2018). ADHD in the United Kingdom: Regional and socioeconomic variations in incidence rates amongst children and adolescents (2004-2013). Journal of Attention Disorders 22(2) 134\u2013142. https:\/\/doi.org\/10.1177\/1087054715613441","DOI":"10.1177\/1087054715613441"},{"key":"e_1_3_3_21_1","doi-asserted-by":"crossref","unstructured":"Holmes E. A. F. Hughes D. A. Morrison V. L. (2014). Predicting adherence to medications using health psychology theories: A systematic review of 20 years of empirical research. Value in Health 17(8) 863\u2013876. https:\/\/doi.org\/10.1016\/j.jval.2014.08.2671","DOI":"10.1016\/j.jval.2014.08.2671"},{"key":"e_1_3_3_22_1","doi-asserted-by":"crossref","unstructured":"Johnson B. Stjepanovic D. Leung J. Chan G. C. K. (2024). \u201cEverything\u2019s a challenge\u201d: An interview study of ADHD individuals in the midst of the prescription stimulant shortage. Journal of Attention Disorders. Advance online publication. https:\/\/doi.org\/10.1177\/10870547241288351","DOI":"10.1177\/10870547241288351"},{"key":"e_1_3_3_23_1","doi-asserted-by":"crossref","unstructured":"Khan M. U. Aslani P. (2021). Exploring factors influencing initiation implementation and discontinuation of medications in adults with ADHD. Health Expectations 24(S1) 82\u201394. https:\/\/doi.org\/10.1111\/hex.13031","DOI":"10.1111\/hex.13031"},{"key":"e_1_3_3_24_1","doi-asserted-by":"crossref","unstructured":"Knecht C. de Alvaro R. Martinez-Raga J. Balanza-Martinez V. (2015). Attention-deficit hyperactivity disorder (ADHD) substance use disorders and criminality: A difficult problem with complex solutions. International Journal of Adolescent Medicine and Health 27(2) 163\u2013175. https:\/\/doi.org\/10.1515\/ijamh-2015-5007","DOI":"10.1515\/ijamh-2015-5007"},{"key":"e_1_3_3_25_1","doi-asserted-by":"crossref","unstructured":"Loe M. Cuttino L. (2008). Grappling with the medicated self: The case of ADHD college students. Symbolic Interaction 31(3) 303\u2013323. https:\/\/doi.org\/10.1525\/si.2008.31.3.303","DOI":"10.1525\/si.2008.31.3.303"},{"key":"e_1_3_3_26_1","doi-asserted-by":"crossref","unstructured":"Long H. A. French D. P. Brooks J. M. (2020). Optimising the value of the critical appraisal skills programme (CASP) tool for quality appraisal in qualitative evidence synthesis. Research Methods in Medicine & Health Sciences 1(1) 31\u201342. https:\/\/doi.org\/10.1177\/2632084320947559","DOI":"10.1177\/2632084320947559"},{"key":"e_1_3_3_27_1","doi-asserted-by":"crossref","unstructured":"Marrero R. J. Fumero A. de Miguel A. Pe\u00f1ate W. (2020). Psychological factors involved in psychopharmacological medication adherence in mental health patients: A systematic review. Patient Education and Counseling 103(10) 2116\u20132131. https:\/\/doi.org\/10.1016\/j.pec.2020.04.030","DOI":"10.1016\/j.pec.2020.04.030"},{"key":"e_1_3_3_28_1","doi-asserted-by":"crossref","unstructured":"Mather B. A. (2012). The social construction and reframing of attention-deficit\/hyperactivity disorder. Ethical Human Psychology and Psychiatry 14(1) 15\u201326. https:\/\/www.proquest.com\/scholarly-journals\/social-construction-reframing-attention-deficit\/docview\/1022266784\/se-2","DOI":"10.1891\/1559-4343.14.1.15"},{"key":"e_1_3_3_29_1","doi-asserted-by":"crossref","unstructured":"Matheson L. Asherson P. Wong I. C. K. Hodgkins P. Setyawan J. Sasane R. Clifford S. (2013). Adult ADHD patient experiences of impairment service provision and clinical management in England: A qualitative study. BMC Health Services Research 13(1) 184. https:\/\/doi.org\/10.1186\/1472-6963-13-184","DOI":"10.1186\/1472-6963-13-184"},{"key":"e_1_3_3_30_1","doi-asserted-by":"crossref","unstructured":"McKechnie D. G. J. O\u2019Nions E. Dunsmuir S. Petersen I. (2023). Attention-deficit hyperactivity disorder diagnoses and prescriptions in UK primary care 2000\u20132018: Population-based cohort study. BJPsych Open 9(4) e121. https:\/\/doi.org\/10.1192\/bjo.2023.512","DOI":"10.1192\/bjo.2023.512"},{"key":"e_1_3_3_31_1","doi-asserted-by":"crossref","unstructured":"Meaux J. B. Hester C. Smith B. Shoptaw A. (2006). Stimulant medications: A trade-off? The lived experience of adolescents with ADHD. Journal for Specialists in Pediatric Nursing 11(4) 214\u2013226. https:\/\/doi.org\/10.1111\/j.1744-6155.2006.00063.x","DOI":"10.1111\/j.1744-6155.2006.00063.x"},{"key":"e_1_3_3_32_1","doi-asserted-by":"crossref","unstructured":"Minde K. Eakin L. Hechtman L. Ochs E. Bouffard R. Greenfield B. Looper K. (2003). The psychosocial functioning of children and spouses of adults with ADHD. Journal of Child Psychology and Psychiatry 44(4) 637\u2013646. https:\/\/doi.org\/10.1111\/1469-7610.00150","DOI":"10.1111\/1469-7610.00150"},{"key":"e_1_3_3_33_1","doi-asserted-by":"crossref","unstructured":"Munthe-Kaas H. Bohren M. A. Glenton C. Lewin S. Noyes J. Tun\u00e7alp \u00d6. Booth A. Garside R. Colvin C. J. Wainwright M. Rashidian A. Flottorp S. Carlsen B. (2018). Applying GRADE-CERQual to qualitative evidence synthesis findings\u2014paper 3: How to assess methodological limitations. Implementation Science 13(S1) 9. https:\/\/doi.org\/10.1186\/s13012-017-0690-9","DOI":"10.1186\/s13012-017-0690-9"},{"key":"e_1_3_3_34_1","unstructured":"National Institute for Health and Care Excellence. (2024). Attention deficit hyperactivity disorder: How common is it? Clinical Knowledge Summaries. https:\/\/cks.nice.org.uk\/topics\/attention-deficit-hyperactivity-disorder\/background-information\/prevalence\/"},{"key":"e_1_3_3_35_1","doi-asserted-by":"publisher","DOI":"10.4135\/9781412985000"},{"key":"e_1_3_3_36_1","doi-asserted-by":"crossref","unstructured":"O\u2019Callaghan P. (2014). Adherence to stimulants in adult ADHD. ADHD Attention Deficit and Hyperactivity Disorders 6(2) 111\u2013120. https:\/\/doi.org\/10.1007\/s12402-014-0129-y","DOI":"10.1007\/s12402-014-0129-y"},{"key":"e_1_3_3_37_1","doi-asserted-by":"crossref","unstructured":"Page M. J. McKenzie J. E. Bossuyt P. M. Boutron I. Hoffmann T. C. Mulrow C. D. Shamseer L. Tetzlaff J. M. Akl E. A. Brennan S. E. Chou R. Glanville J. Grimshaw J. M. Hr\u00f3bjartsson A. Lalu M. M. Li T. Loder E. W. Mayo-Wilson E. McDonald S. . . . Moher D. (2021). The PRISMA 2020 statement: An updated guideline for reporting systematic reviews. BMJ 372 n71. https:\/\/doi.org\/10.1136\/bmj.n71","DOI":"10.1136\/bmj.n71"},{"key":"e_1_3_3_38_1","doi-asserted-by":"crossref","unstructured":"Rashid M. A. Lovick S. Llanwarne N. R. (2018). Medication-taking experiences in attention deficit hyperactivity disorder: A systematic review. Family Practice 35(2) 142\u2013150. https:\/\/doi.org\/10.1093\/fampra\/cmx088","DOI":"10.1093\/fampra\/cmx088"},{"key":"e_1_3_3_39_1","unstructured":"Ring N. Ritchie K. Mandava L. Jepson R. (2010). A guide to synthesising qualitative research for researchers undertaking health technology assessments and systematic reviews. NHS Quality Improvement Scotland (NHS QIS). http:\/\/hdl.handle.net\/1893\/3205"},{"key":"e_1_3_3_40_1","doi-asserted-by":"crossref","unstructured":"Rosenstock I. M. (1974). Historical origins of the health belief model. Health Education Monographs 2(4) 328\u2013335. https:\/\/doi.org\/10.1177\/109019817400200403","DOI":"10.1177\/109019817400200403"},{"key":"e_1_3_3_41_1","doi-asserted-by":"crossref","unstructured":"Sattar R. Lawton R. Panagioti M. Johnson J. (2021). Meta-ethnography in healthcare research: A guide to using a meta-ethnographic approach for literature synthesis. BMC Health Services Research 21(1) 50. https:\/\/doi.org\/10.1186\/s12913-020-06049-w","DOI":"10.1186\/s12913-020-06049-w"},{"key":"e_1_3_3_42_1","doi-asserted-by":"crossref","unstructured":"Schaefer M. R. Rawlinson A. R. Wagoner S. T. Shapiro S. K. Kavookjian J. Gray W. N. (2017). Adherence to attention-deficit\/hyperactivity disorder medication during the transition to college. Journal of Adolescent Health 60(6) 706\u2013713. https:\/\/doi.org\/10.1016\/j.jadohealth.2016.12.011","DOI":"10.1016\/j.jadohealth.2016.12.011"},{"key":"e_1_3_3_43_1","doi-asserted-by":"crossref","unstructured":"Shaw R. L. Booth A. Sutton A. J. Miller T. Smith J. A. Young B. Jones D. R. Dixon-Woods M. (2004). Finding qualitative research: An evaluation of search strategies. BMC Medical Research Methodology 4(1) 5. https:\/\/doi.org\/10.1186\/1471-2288-4-5","DOI":"10.1186\/1471-2288-4-5"},{"key":"e_1_3_3_44_1","doi-asserted-by":"crossref","unstructured":"Smith M. C. F. Mukherjee R. A. S. M\u00fcller-Sedgwick U. Hank D. Carpenter P. Adamou M. (2024). UK adult ADHD services in crisis. BJPsych Bulletin 48(1) 1\u20135. https:\/\/doi.org\/10.1192\/bjb.2023.88","DOI":"10.1192\/bjb.2023.88"},{"key":"e_1_3_3_45_1","doi-asserted-by":"crossref","unstructured":"Song P. Zha M. Yang Q. Zhang Y. Li X. Rudan I. (2021). The prevalence of adult attention-deficit hyperactivity disorder: A global systematic review and meta-analysis. Journal of Global Health 11 Article 04009. https:\/\/doi.org\/10.7189\/jogh.11.04009","DOI":"10.7189\/jogh.11.04009"},{"key":"e_1_3_3_46_1","doi-asserted-by":"crossref","unstructured":"Spencer A. E. Faraone S. V. Bogucki O. E. Pope A. L. Uchida M. Milad M. R. Spencer T. J. Woodworth K. Y. Biederman J. (2016). Examining the association between posttraumatic stress disorder and attention-deficit\/hyperactivity disorder. The Journal of Clinical Psychiatry 77(01) 72\u201383. https:\/\/doi.org\/10.4088\/JCP.14r09479","DOI":"10.4088\/JCP.14r09479"},{"key":"e_1_3_3_47_1","doi-asserted-by":"crossref","unstructured":"Surman C. B. H. Hammerness P. G. Pion K. Faraone S. V. (2013). Do stimulants improve functioning in adults with ADHD? European Neuropsychopharmacology 23(6) 528\u2013533. https:\/\/doi.org\/10.1016\/j.euroneuro.2012.02.010","DOI":"10.1016\/j.euroneuro.2012.02.010"},{"key":"e_1_3_3_48_1","doi-asserted-by":"crossref","unstructured":"Vrijsen J.N. Tendolkar I. Onnink M. Moogman M. Schene A. H. Fernandez G. Van Oostrom I. Franke B. (2018). ADHD symptoms in healthy adults are associated with stressful life events and negative memory bias. ADHD Attention Deficit and Hyperactivity Disorders 10 151\u2013160. https:\/\/doi.org\/10.1007\/s12402-017-0241-x","DOI":"10.1007\/s12402-017-0241-x"},{"key":"e_1_3_3_49_1","doi-asserted-by":"crossref","unstructured":"Young S. Thome J. (2011). ADHD and offenders. The World Journal of Biological Psychiatry 12(1) 124\u2013128. https:\/\/doi.org\/10.3109\/15622975.2011.600319","DOI":"10.3109\/15622975.2011.600319"},{"key":"e_1_3_3_50_1","doi-asserted-by":"crossref","unstructured":"Zulauf C. A. Sprich S. E. Safren S. A. Wilens T. E. (2014). The complicated relationship between attention deficit\/hyperactivity disorder and substance use disorders. Current Psychiatry Reports 16(3) 436. https:\/\/doi.org\/10.1007\/s11920-013-0436-6","DOI":"10.1007\/s11920-013-0436-6"}],"container-title":["Journal of Attention Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/10870547251349952","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/10870547251349952","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/10870547251349952","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T19:30:31Z","timestamp":1777491031000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/10870547251349952"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,16]]},"references-count":49,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["10.1177\/10870547251349952"],"URL":"https:\/\/doi.org\/10.1177\/10870547251349952","relation":{},"ISSN":["1087-0547","1557-1246"],"issn-type":[{"value":"1087-0547","type":"print"},{"value":"1557-1246","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,16]]}}}